The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(E)-N-(4-Bromophenyl)-7-cyano-6-((4-hydroxybenzylidene)amino)-2,3-dihydro-1H-pyrrolizine-5-carboxamide ID: ALA4557315
PubChem CID: 155554424
Max Phase: Preclinical
Molecular Formula: C22H17BrN4O2
Molecular Weight: 449.31
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: N#Cc1c(/N=C/c2ccc(O)cc2)c(C(=O)Nc2ccc(Br)cc2)n2c1CCC2
Standard InChI: InChI=1S/C22H17BrN4O2/c23-15-5-7-16(8-6-15)26-22(29)21-20(18(12-24)19-2-1-11-27(19)21)25-13-14-3-9-17(28)10-4-14/h3-10,13,28H,1-2,11H2,(H,26,29)/b25-13+
Standard InChI Key: RUYOIFKVHOOUJH-DHRITJCHSA-N
Molfile:
RDKit 2D
29 32 0 0 0 0 0 0 0 0999 V2000
30.0552 -4.3213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.5544 -3.6729 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0085 -2.9904 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8005 -3.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8272 -4.0377 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
31.6165 -4.2689 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0792 -3.5882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.5733 -2.9389 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8083 -2.1508 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.0353 -1.3617 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.9001 -3.5615 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3316 -4.2596 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.1525 -4.2287 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.8983 -5.0374 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3675 -5.6664 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.7069 -5.1853 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
31.6452 -6.4390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1147 -7.0654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3919 -7.8375 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.2012 -7.9819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.7328 -7.3480 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4487 -6.5784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4801 -8.7500 0.0000 Br 0 0 0 0 0 0 0 0 0 0 0 0
34.5868 -4.9244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.4070 -4.8939 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7915 -4.1670 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3499 -3.4693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5312 -3.5032 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.6081 -4.1353 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
3 2 1 0
4 3 1 0
4 5 1 0
1 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 4 2 0
9 10 3 0
8 9 1 0
7 11 1 0
11 12 2 0
12 13 1 0
6 14 1 0
14 15 1 0
14 16 2 0
15 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 17 1 0
20 23 1 0
13 24 2 0
24 25 1 0
25 26 2 0
26 27 1 0
27 28 2 0
28 13 1 0
26 29 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 449.31Molecular Weight (Monoisotopic): 448.0535AlogP: 4.78#Rotatable Bonds: 4Polar Surface Area: 90.41Molecular Species: NEUTRALHBA: 5HBD: 2#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.12CX Basic pKa: ┄CX LogP: 4.73CX LogD: 4.66Aromatic Rings: 3Heavy Atoms: 29QED Weighted: 0.56Np Likeness Score: -1.30
References 1. Shawky AM, Abourehab MAS, Abdalla AN, Gouda AM.. (2020) Optimization of pyrrolizine-based Schiff bases with 4-thiazolidinone motif: Design, synthesis and investigation of cytotoxicity and anti-inflammatory potency., 185 [PMID:31655429 ] [10.1016/j.ejmech.2019.111780 ]